Cosmo announces license of Lumeblue™ (Methylene Blue MMX) EU rights to Alfasigma
Cosmo Pharmaceuticals NV today announced that it has licensed the EU rights (plus Switzerland, UK, EEA countries, Russia and Mexico) for Lumeblue™ to Alfasigma S.p.A. Lumeblue™ is Cosmo’s recently EMA approved drug for the detection of lesions during colonoscopy.